Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Eflornithine

EU orphan designation number: EU/3/11/902   
Active ingredient: Eflornithine
Indication: Treatment of neuroblastoma
Sponsor: Cancer Prevention Pharma Limited
c/o Arnold & Porter (UK) LLP, Tower 42, 25 Old Broad Street, London EC2N 1HQ, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
29/09/2011 Centralised Orphan - Designation EMA/OD/126/10 (2011)7035 of 27/09/2011